Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of surgical-site infection in hip and knee arthroplasty with perioperative mupirocin nasal ointment and chlorhexidine soap
2010-022701-17Phase 4Active
- Sponsor
- Isala
- Start
- Nov 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in surgical site infection (SSI), Staphylococcus aureus infection and bacterial disease comparing Active mupirocin + chlorhexidine with Placebo regimen (2 arms). Primary endpoint: Incidence of surgical-site infections due to Staphylococcus aureus. Started Nov 2015; status: active.
02
Drugs
mupirocinchlorhexidine
03
Conditions
surgical site infection (SSI)Staphylococcus aureus infectionbacterial disease
Beyond the preview
Go deeper on 2010-022701-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022701-17.